Cellebration Life Sciences
Phoenix, US · Founded 2020 · Wyoming corporation
Founders & leadership
AS
Anand SrivastavaNamed on SEC filing
DP
Deven PatelNamed on SEC filing
BD
Bill DeeganNamed on SEC filing
TK
Tim KopatichNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 1 round · 2021
▶$2.8MraisedAug 2023 · 63 investors · BiotechnologyRule 506(c)
▶$2.8MraisedAug 2023 · 63 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Anand SrivastavaDirector
- Deven PatelDirector
- Bill DeeganDirector
- Tim KopatichExecutive Officer
- Offering amount
- $20M
- Amount sold
- $2.8M
- Minimum investment
- $25K
- Proceeds to insiders
- $590K
- First sale
- Jan 2021
- Incorporated
- Corporation, Wyoming, 2020
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cellebration Life Sciences raised?
- Cellebration Life Sciences has disclosed $2.8M raised across 1 round.
- Where is Cellebration Life Sciences headquartered?
- Cellebration Life Sciences is headquartered in Phoenix, US.